In a GIST cell-derived mouse xenograft model, spautin-1 triggers ATG5 degradation, and its use with 3-methyladenine notably enhances the therapeutic impact of IM [158]. This evidence concerns the gene ATG5 and gastrointestinal stromal tumor.